SynthesisAnnals of medicine2025
Low eosinophils and their dynamic as a predictor of death in patients with infections: a systematic review and meta-analysis of cohort studies.
Synthesis in Annals of medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Static and Dynamic Eosinophil Measures and In-Hospital Mortality in Patients with Sepsis: A Retrospective Cohort Study.Medicina (Kaunas, Lithuania) · 2026Observational
- Eosinopenia and prognosis in severe community-acquired pneumonia.Pneumonia (Nathan Qld.) · 2026Article
- Early increase in red cell distribution width-to-platelet ratio is associated with poor prognosis in sepsis patients: a retrospective cohort study.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEosinophils prognostic significance in predicting mortality has become particularly notable during the COVID-19 pandemic. We aimed to evaluate the prognostic value of peripheral low eosinophil (eosinopenia) with focus on their dynamics (eosinophil recovery) in patients with infections.
methodsWe searched databases (MEDLINE, Embase, Scopus, Web of Science, and the Cochrane Library) and additional sources from inception to 1 December 2023. Cohort studies involving adult patients hospitalized with infections were evaluated using dual-reviewer methodology.
resultsOut of 15,066 screened papers, 151 studies met the inclusion criteria, with 107 focused on COVID-19, 14 on sepsis, 9 on
conclusionsEosinopenia, particularly the trajectory of eosinophil recovery, may serve as a cost-effective and accessible prognostic marker for mortality in patients with infections.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.